688073 Bide Pharmatech
- 32.70
- -0.20-0.61%
Bide Pharmatech News
Announcement of Resolutions of the Shareholders' Meeting for the Fiscal Year 2023
Legal Opinion on the 2023 Annual Shareholders Meeting of Shanghai Bide Pharmaceutical Technology Co., Ltd.
2023 Annual General Meeting of Shareholders Meeting Materials
Announcement on By-election of Independent Directors of the 2nd Board of Directors and Members of the Special Committee of the Board
Notice on convening the 2023 Annual General Meeting of Shareholders
Announcement on the resignation of an independent director
Announcement on the Company and its wholly-owned subsidiaries applying for comprehensive credit lines and providing guarantees in 2024
2023 Internal Control Evaluation Report
2023 Audit Committee Performance Report
Special report of the board of directors on the self-inspection of the independence of independent directors
Independent Director's Debriefing Report - Tian Weisheng (has completed his term and left office)
Independent Director's Debriefing Report - Zhang Meng (has completed her term and left office)
Independent Director's Debriefing Report - Wei Wei (has completed his term and left office)
2024 “Improve Quality, Increase Efficiency, and Focus on Return” Action Plan
Accounting Services Selection and Hiring System
Notice on amending the “Articles of Association”, registering industrial and commercial changes, and revising part of the company's governance system
Notice on requesting the shareholders' meeting to authorize the board of directors to handle matters relating to microfinance
Announcement on the shareholding situation of the top ten shareholders and the top ten shareholders with unlimited sale conditions for share repurchases
Announcement of Resolutions of the 2023 Third Extraordinary General Meeting of Shareholders
Legal Opinion of the 2023 Third Extraordinary General Meeting of Shareholders
Analysis
Price Target
No Data
